Skip to content
Newsroom

$4M Funding Furthers Belluscura’s U.S. Expansion Goals

Sallyport Commercial Finance is delighted to announce a $4,000,000 funding facility for Belluscura, a trailblazing medical device company focused on developing innovative oxygen enrichment technology. The funding, comprising accounts receivable and cash flow loans, will empower Belluscura to expand its operations into the U.S. market, supporting the production and distribution of their groundbreaking oxygen treatment devices.

Belluscura is on a mission to improve health outcomes for patients with Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Their enriched oxygen treatment platforms are designed to enhance patient care while delivering favorable economic outcomes for healthcare providers and insurance companies. By innovating rapidly and navigating regulatory pathways efficiently, Belluscura aims to reduce treatment costs, increase available options and deliver value to patients.

The strategic move to secure funding from Sallyport comes at a critical time for Belluscura, as they prepare for the formal launch of their device in 2025 following a successful soft launch. This financial boost will enable the company to scale production and capitalize on growing demand in the business-to-business market.

Nick Hart, President of Sallyport Commercial Finance, shared his excitement about the partnership:

“Sallyport is proud to fuel innovation and growth for companies like Belluscura. This funding underscores our commitment to empowering businesses to deliver life-enhancing solutions, such as their groundbreaking oxygen devices, to a global market.”

This partnership highlights Sallyport’s unique ability to support UK-owned subsidiaries operating in North America, where other lenders often hesitate. By working closely with Cadence Advisory, Sallyport was able to provide the financial resources Belluscura needs to achieve its ambitious goals.

Belluscura’s dedication to improving healthcare outcomes and reducing treatment costs aligns perfectly with Sallyport’s mission to empower businesses to thrive and achieve a meaningful impact in their industries.

For more information on how Sallyport can support your business growth, reach out to us today!

Posted in
  • News

Canadian Oilfield Services Gets $4,000,000 Funding Boost

November 28, 2024

We are thrilled to announce that Sallyport has successfully provided $4 million in Accounts Receivable funding to a dynamic client…

Read More

Sallyport Fuels $250K Comeback for Wholesale Startup Growth

October 28, 2024

Sallyport Commercial Finance is proud to announce a new funding for a Canadian client in the wholesale and distribution industry,…

Read More
  • Articles

COVID-19: Catalyst or Concern for the Telecoms Industry

The telecoms industry is made up of diverse sectors and has so far suffered an equally diverse range of impacts…

Read More

UK Firms Consider Move Across the Pond

Over 6-months following the UK’s official exit from Europe and the implications for UK-based exporting businesses remain murky. Many larger…

Read More
  • Videos

sallyport commercial finance logo

What is an Entrepreneur?

View Now

American Business Women’s Day

Sallyport Commercial Finance Celebrates American Business Women’s Day  

View Now
Scroll To Top